GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a major focus in therapeutic research, largely due to its impressive impact on managing conditions such as adult-onset diabetes and weight gain. Ongoing trials have shown that more than glucose control, GLP-1 medications offer promise for circulatory health and perhaps neuro